Who is sponsoring NCT06272357?

NCT06272357 is sponsored by Assiut University.

What drugs are being tested in NCT06272357?

Interventions in NCT06272357: Antiarrhythmic drugs.

What condition does NCT06272357 study?

NCT06272357 studies Antiarrhythmic Drug Adverse Reaction.

Is NCT06272357 still recruiting?

NCT06272357 is currently status unknown. Last updated 22 February 2024.

Last reviewed 2024-02-22 · How we verify

NCT06272357

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Use of Antiarrhythmic Drugs in Pediatrics

Status unknown Last updated 22 February 2024

What this trial tests

trial testing Antiarrhythmic drugs in Antiarrhythmic Drug Adverse Reaction in 158 participants. Status unknown.

Timeline

1 April 2024

Primary endpoint
31 December 2024

31 March 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	158
Start date	1 April 2024
Primary completion	31 December 2024
Estimated completion	31 March 2025

Drugs / interventions tested

Antiarrhythmic drugs — full drug profile →

Conditions studied

Antiarrhythmic Drug Adverse Reaction — all drugs for Antiarrhythmic Drug Adverse Reaction →

Sponsor

Assiut University

Who can join

Adults 30 Days to 18, any sex, with Antiarrhythmic Drug Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A study on the use of antiarrhythmic drugs in pediatric age group, in Assiut University Children's Hospital, a clinical audit

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Antiarrhythmic drugs

Trials testing the same drug.

NCT03299517 — PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN SVT · Phase 4 · unknown

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06272357 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06272357.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing